MX2009008572A - Aerosoles estables con farmaco de grado farmaceutico. - Google Patents

Aerosoles estables con farmaco de grado farmaceutico.

Info

Publication number
MX2009008572A
MX2009008572A MX2009008572A MX2009008572A MX2009008572A MX 2009008572 A MX2009008572 A MX 2009008572A MX 2009008572 A MX2009008572 A MX 2009008572A MX 2009008572 A MX2009008572 A MX 2009008572A MX 2009008572 A MX2009008572 A MX 2009008572A
Authority
MX
Mexico
Prior art keywords
drug product
container
fine particle
pharmaceutical drug
ambient conditions
Prior art date
Application number
MX2009008572A
Other languages
English (en)
Inventor
Jill K Sherwood
Joel Sequeira
Brent A Donovan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX2009008572A publication Critical patent/MX2009008572A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Varios aspectos de la presente invención estipulan métodos para fabricar un producto de fármaco de grado farmacéutico, que incluyen almacenar un contenedor a una temperatura mayor que las condiciones ambientales por al menos alrededor de siete días y realizar pruebas de liberación del contenedor después del almacenamiento; los productos fabricados mediante este método tienen una distribución de tamaño de partícula fina (FSD) más consistente y una fracción de partículas finas (FPF) en condiciones ambientales y en condiciones de estabilidad acelerada en el transcurso de la duración del producto de fármaco; convenientemente, tales productos pueden pasar de manera más confiable y regular los requerimientos de prueba requeridos para un producto de fármaco aprobado por dependencias reguladoras como la Agencia de Alimentos y Fármacos de los Estados Unidos (USFDA).
MX2009008572A 2007-02-09 2007-02-09 Aerosoles estables con farmaco de grado farmaceutico. MX2009008572A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/003637 WO2008097233A1 (en) 2007-02-09 2007-02-09 Stable pharmaceutical drug aerosols

Publications (1)

Publication Number Publication Date
MX2009008572A true MX2009008572A (es) 2009-10-19

Family

ID=38610578

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008572A MX2009008572A (es) 2007-02-09 2007-02-09 Aerosoles estables con farmaco de grado farmaceutico.

Country Status (10)

Country Link
EP (2) EP2117504A1 (es)
JP (1) JP2010518076A (es)
KR (1) KR20100004993A (es)
CN (1) CN101652123A (es)
AU (1) AU2007346134A1 (es)
BR (1) BRPI0721256A2 (es)
CA (1) CA2677347A1 (es)
MX (1) MX2009008572A (es)
NO (1) NO20092977L (es)
WO (1) WO2008097233A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011136754A1 (en) * 2010-04-26 2011-11-03 Mahmut Bilgic A medicament developed for the treatment of respiratory diseases
EP3203983A1 (en) * 2014-10-08 2017-08-16 Eratech S.r.l. Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
BR122020022602B1 (pt) 2015-12-04 2024-03-05 Mexichem Fluor S.A. De C.V. Composição farmacêutica
CN107961217B (zh) * 2016-10-18 2021-06-29 天津金耀集团有限公司 一种糠酸莫米松气雾剂组合物
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
KR100316358B1 (ko) * 1996-08-29 2001-12-12 둘락 노먼 씨. 클로로플루오로카본 비함유 모메타손 푸로에이트 에어로졸 제형
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
EP1241113A1 (en) * 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
JP4679901B2 (ja) 2002-08-27 2011-05-11 シェーリング コーポレイション 定量吸入処方物を産生するためのプロセス
CN1870976A (zh) * 2003-10-20 2006-11-29 先灵公司 药物组合物

Also Published As

Publication number Publication date
BRPI0721256A2 (pt) 2013-03-12
CN101652123A (zh) 2010-02-17
EP2444080A2 (en) 2012-04-25
CA2677347A1 (en) 2008-08-14
WO2008097233A1 (en) 2008-08-14
EP2117504A1 (en) 2009-11-18
EP2444080A3 (en) 2012-05-02
JP2010518076A (ja) 2010-05-27
AU2007346134A1 (en) 2008-08-14
KR20100004993A (ko) 2010-01-13
NO20092977L (no) 2009-11-02

Similar Documents

Publication Publication Date Title
MX2009008572A (es) Aerosoles estables con farmaco de grado farmaceutico.
MX2019003804A (es) Dispositivos implantables para suministro de medicamento con liberacion de descarga reducida.
NZ769177A (en) Cannabis extracts and methods of preparing and using same
MX2015002117A (es) Metodo y sistema para dispensar una composicion.
EP4238597A3 (en) The invention relates to a drug delivery device
BR112014019010A8 (pt) Tampa de recipiente para remédio
MX340924B (es) Composiciones farmaceuticas.
WO2008021776A3 (en) Automated system and process for filling drug delivery devices of multiple sizes
WO2007133660A3 (en) System, method and corresponding apparatus for storing, retrieving and delivering unit dose blisters
WO2009050646A8 (en) Multi-compartmented container
BR112016023620A2 (pt) frasco, sistema que compreende tal frasco e método para produção do mesmo
MX2013002006A (es) Paquetes de suministro y metodos y sistemas para fabricar paquetes de suministro.
BR112015002913A2 (pt) sistema para conter uma pilha de pluralidade de máscaras faciais e dispensar máscaras faciais individuais da pilha e método de embalar uma pluralidade de máscaras faciais no interior de um recipiente.
EP4316473A3 (en) Use of stearate in an inhalable formulation
BR112014022944A2 (pt) Sistema de distribuição aérea para distribuir itens
EP3506871A4 (en) METHOD AND SYSTEM FOR STORING DRUGS IN DISPENSING PACKAGES AND STORING FOR PACKAGING DELIVERY PACKAGES
WO2009135949A3 (en) Process for preparing a very high drug load tablet
LT4197528T (lt) Kompozicijos, būdai ir sistemos, skirtos aerozolinių vaistų pristatymui
BR112015026944A2 (pt) aparelho e método para dispensação de pesos de balanceamento de veículo
WO2016061433A3 (en) Medication dosage indicator
WO2015028670A3 (en) Method for the fabrication of multi-layered micro-containers for drug delivery
MX2018007977A (es) Forma farmaceutica osmotica de liberacion extendida que contiene una carga de clorhidrato de metilfenidato alta.
AU2019902040A0 (en) Method and device for respiratory drug delivery
Nunnelee Review of an Article: Self-management for oral anticoagulation (2009). Garcia-Alamino JM, Martin JLR, Subirana M & Gich I. Cochrane, Database of Systematic Reviews 4 (CD003839
BR112016007614A2 (pt) método e instalação para o enchimento de peso de recipientes sobre uma esteira

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: DUBOIS CHEMICALS, INC.

FA Abandonment or withdrawal